Catherine A. Sohn has an estimated net worth of $6.89 Million. This is based on reported shares across multiple companies, which include Jazz Pharmaceuticals plc, LANDEC CORP \CA\, Rubius Therapeutics, Inc., Neuralstem, Inc., Axcella Health Inc., Altimmune, Inc., and Maze Therapeutics, Inc..

2020 was Catherine A. Sohn's most active year for acquiring shares with 10 total transactions. Catherine A. Sohn's most active month to acquire stocks was the month of July. 2020 was Catherine A. Sohn's most active year for disposing of shares, totalling 7 transactions. Catherine A. Sohn's most active month to dispose stocks was the month of July. 2020 saw Catherine A. Sohn paying a total of $836,162.00 for 75,473 shares, this is the most they've acquired in one year. In 2020 Catherine A. Sohn cashed out on 34,131 shares for a total of $2,035,185.71, their largest year based on trade value.